Inhibitors of F18+ E Coli Binding

The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic Escherichia coli and the use of compounds comprising such determinants for the treatment of F18+ E. coli infections in pigs and in screening methods.

Attached files:
2010037785.jpg

Patents:
WO 2,010,037,785

Inventor(s): CODDENS ANNELIES [BE]; COX ERIC [BE]; TENEBERG SUSANN EVA [SE]

Type of Offer: Sale



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent